Key Market Indicator:
Ad-hoc news is mandatory information from listed companies that must be made available to investors. Depending on the occasion and content of the news, it can have an impact on the share price. The newsfeed covers a wide range of topics relevant to investor relations and is recommended as an important source of information before making an investment decision.
Tue, 11.08.2026
thyssenkrupp nucera AG & Co. KGaA
thyssenkrupp nucera AG & Co. KGaA ("thyssenkrupp nucera") has decided, following a comprehensive strategic review of market readiness, investment requirements and economic prospects, to no longer pursue its activities aimed at establishing its own capacities for the mass production of Solid Oxide Electrolysis Cells (SOEC) stacks. In connection [ … ]
Tue, 11.08.2026
Medios AG
Medios AG – Acquisition of a Majority Stake in Caesar & Loretz GmbH (Caelo) and Entry into the German Market for Active Pharmaceutical Ingredients and Excipients
Berlin, 11. August 2026 – Medios AG (ISIN: DE000A1MMCC8, Medios) today signed an agreement to acquire 74% of the shares in Caesar & Loretz GmbH (Caelo), based in Hilden. Caelo is [ … ]
Mon, 10.08.2026
Amrize Ltd
CHICAGO/ZUG, Switzerland, August 10, 2026 – Amrize (AMRZ) has filed its Form 10-Q for the Second Quarter and First Half Year 2026 with the U.S. Securities and Exchange Commission. The report is also available on Amrize’s website at https://investors.amrize.com/
About AmrizeAmrize (NYSE: AMRZ) is building North America, as the partner of choice for [ … ]
Mon, 10.08.2026
ARYZTA AG
Ad hoc announcement pursuant to article 53 LR
PDF Downloadlink
About ARYZTA
ARYZTA AG (‘ARYZTA’) is an international bakery company with a leadership position
in convenience bakery. ARYZTA is based in Schlieren, Switzerland, with operations in
Europe, Asia, Australia and New Zealand. ARYZTA is listed on the SIX Swiss Exchange
(SIX: ARYN)
End of In [ … ]
Fri, 07.08.2026
RHÖN-KLINIKUM Aktiengesellschaft
Asklepios Kliniken GmbH & Co. KGaA with registered office in Hamburg today submitted the request to the management board of RHÖN-Klinikum Aktiengesellschaft that the general meeting of RHÖN-Klinikum Aktiengesellschaft resolves upon the transfer of the shares of the minority shareholders of RHÖN-Klinikum Aktiengesellschaft to Asklepios Kliniken [ … ]
Fri, 07.08.2026
Brenntag SE
INSIDERINFORMATION ACCORDING TO ART. 17 EU-MARKET ABUSE REGULATION (MAR – REGULATION (EU) No 596/2024)
Brenntag SE raises operating EBITDA guidance for the fiscal year 2026
Brenntag SE (ISIN: DE000A1DAHH0) raises its operating EBITDA guidance for the fiscal year 2026. Based on a continuously positive start to the third quarter, Brenntag now [ … ]
Fri, 07.08.2026
Cicor Technologies Ltd
Ad hoc announcement pursuant to Art. 53 LR
Bronschhofen, 7 August 2026 – Cicor Group (SIX Swiss Exchange: CICN) has signed a new CHF 425 million unsecured term and revolving credit facilities agreement, replacing its existing credit facilities well ahead of their maturity in autumn 2027. Commitments from existing and new banking partners significan [ … ]
Fri, 07.08.2026
Mobimo Holding AG
Ad hoc announcement pursuant to Art. 53 LR
Mobimo with strong operational performance in the first half of 2026
Rental income increased to CHF 74.2 million – a rise of 2.2% compared with the previous year.
Encouraging net income from development projects and sale of trading properties of CHF 19.5 million – due to strong sales and projects [ … ]
Thu, 06.08.2026
Galenica AG
Press releaseAd hoc announcement pursuant to Art. 53 LR
Galenica increases sales by 7.1% to CHF 2,136.5 million in the first half of 2026.
Adjusted1 EBIT increases by 7.1% to CHF 117.7 million.
Demand for healthcare services in pharmacies continues to increase.
Home care and diagnostics are establishing themselves as important growth drivers.
G [ … ]
Wed, 05.08.2026
Enapter AG
Disclosure of inside information pursuant to Article 17 of Regulation (EU) No 596/2014 (Market Abuse Regulation – MAR)
Enapter AG: Agreement with Patrimonium to discharge corporate bond liabilities of around EUR 26 million; realignment to an asset-light business model; capital measure planned
Strategic realignment towards an asset-light business [ … ]
